Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Lux Capital

Lux Capital
VC INVESTOR TYPE
Active STATUS
15 PROFESSIONALS
225 INVESTMENTS
93 PORTFOLIO
26 EXITS
Description

Lux Capital is a venture capital firm that prefers to invest in emerging technologies and healthcare sectors. The firm was established in 2002 and is based in New York, New York.

Investor Status
Actively Seeking New Investments
Year Founded
2000
Primary Investor Type
Venture Capital
Primary Office
  • 920 Broadway
  • 11th Floor
  • New York, NY 10010
  • United States

+1 (646) 000-0000

Lux Capital Investments (225)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
Cala Health 21-May-2019 Later Stage VC 0000 Therapeutic Devices Generating Revenue
000000 15-Mar-2019 00000 00000 0000 Information Services (B2C) Generating Revenue 000000 00000
00000000000000 13-Mar-2019 0000 00000 00.00 Other Software Startup
0000000000 05-Mar-2019 00000 00000 0000 Multimedia and Design Software Generating Revenue 00000 0é0000
000000 25-Feb-2019 00000 00000 0000 Automation/Workflow Software Generating Revenue 00000 000000 00.0
0000-0000 22-Feb-2019 00000 00000 0000 Electronic Equipment and Instruments Startup 000000 00000
0000000 19-Feb-2019 00000 00000 000.00 Social/Platform Software Generating Revenue/Not Profitable
000000 000000 31-Jan-2019 00000 00000 00.00 Other Healthcare Technology Systems Generating Revenue
Desktop Metal 23-Jan-2019 Later Stage VC 00000 Electrical Equipment Generating Revenue 00000 000000 00.0
Tempo (PCB assembly automation software) 14-Jan-2019 Later Stage VC 0000 Computers, Parts and Peripherals Generating Revenue 000000 000
To view this investor’s complete investment and acquisition history, request access »
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Lux Capital’s full profile, request a free trial.

Lux Capital Exits (26)

Company Name Exit Date Exit Type Exit Size Status Buyers
Authorea 25-Feb-2019 Merger/Acquisition Completed
00000 13-Feb-2019 000000000000000000 00.000 Completed
  • 0000000 & 0000000
0000000 07-Feb-2019 000000000000000000 00000 Completed
  • 00000 0000000
00000000 31-Jan-2019 000000000000000000 Completed
  • 000000
00000000 31-Aug-2018 000000000000000000 00000 Completed
  • 000000 00000000000
000000 0000000 31-Dec-2017 0000000000: 000000 Completed
0000000000 03-Oct-2017 000000000000000000 Completed
  • 000000000
0000 0000000000000 20-Jul-2017 000 0000 Completed
Cerulean Pharma 19-Jul-2017 Merger/Acquisition Completed
Lux Research 05-Jun-2017 Buyout/LBO Completed
To view this investor’s complete exits history, request access »

Lux Capital Team (31)

Name Title Deals Funds Boards Office Contact
Info
Segolene Scarborough Chief Financial Officer Menlo Park, CA
Steven Brody Chief Operating Officer New York, NY
Joshua Wolfe Co-Founder & Managing Partner 00 0 0 New York, NY
Peter Hébert Co-Founder & Managing Partner 00 0 0 New York, NY
Adam Kalish General Partner 0 New York, NY

8 Former Team Members

You’re viewing 5 of 31 team members. Get the full list »